Monographie - Enoxaparin sodium

Siste oppdatering :
08/05/2024

Enoxaparin sodium

Kjemisk struktur

Handelsnavn

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Bolentax	Mexico
Clasina	Colombia
Clenox	Colombia, Peru
Clexan	Hellas
Clexane	Argentina, Australia, Belgia, Brasil, Chile, Colombia, De forente arabiske emirater, Egypt, Iran, Irland, Japan, Kroatia, Luxembourg, Mexico, Nederland, New Zealand, Peru, Polen, Romania, Saudi-Arabia, Spania, Storbritannia, Sveits, Sør-Afrika, Tyrkia, Tyskland, Venezuela
Cutenox	Peru
Dilutol	Argentina, Ecuador
Dynalin	India
Enoparin	Venezuela
Enoxalon	Chile
Enoxanorth	Argentina
Enoxatal	Colombia
Hemofagin	Chile
Heptron	Brasil
Inhixa	Tyskland
Klexane	Danmark, Finland, Norge, Sverige
Lorapine	Argentina
Lovenox	Canada, Frankrike, USA, Østerrike
Lowparin	Colombia
Nurox	Chile

Referanser : Enoxaparin sodium

	Type	Publikasjon
311	Journal	Newborn AL, Kessler JM, Joyner KA. Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Am J Health-Syst Pharm 1996 ; 53: 167-169.
811	Journal	Charland SL, Davis DD, Tillman DJ. Activity of enoxaparin sodium in tuberculin syringes for 10 days. Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
1893	Journal	Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. Anti-Xa stability of diluted enoxaparin for use in pediatrics. Ann Pharmacotherapy 2004 ; 38: 569-573.
2231	Journal	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3643	Labratorium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
4413	Journal	Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution. J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.

Mentions Légales